46
Views
0
CrossRef citations to date
0
Altmetric
Research Article

FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth

, , &
Pages 113-123 | Received 07 Sep 2022, Accepted 22 Nov 2023, Published online: 14 May 2024

References

  • Arnaiz E, Sole C, Manterola L, Iparraguirre L, Otaegui D, Lawrie CH. 2019. CircRNAs and cancer: biomarkers and master regulators. Semin Cancer Biol. 58:90–99. doi: 10.1016/j.semcancer.2018.12.002.
  • Bai N, Peng E, Qiu X, Lyu N, Zhang Z, Tao Y, Li X, Wang Z. 2018. circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. J Exp Clin Cancer Res. 37(1):172. eng. doi: 10.1186/s13046-018-0838-8.
  • Burd EM. 2003. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 16(1):1–17. doi: 10.1128/CMR.16.1.1-17.2003.
  • Chen LL. 2016. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 17(4):205–211. doi: 10.1038/nrm.2015.32.
  • Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. 2013. Human papillomavirus and cervical cancer. Lancet. 382(9895):889–899. doi: 10.1016/S0140-6736(13)60022-7.
  • Dang Y, Yan L, Hu B, Fan X, Ren Y, Li R, Lian Y, Yan J, Li Q, Zhang Y, et al. 2016. Tracing the expression of circular RNAs in human pre-implantation embryos. Genome Biol. 17(1):130. doi: 10.1186/s13059-016-0991-3.
  • de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11(11):1048–1056. doi: 10.1016/S1470-2045(10)70230-8.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386. doi: 10.1002/ijc.29210.
  • Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. 2013. Natural RNA circles function as efficient microRNA sponges. Nature. 495(7441):384–388. doi: 10.1038/nature11993.
  • Hausser J, Zavolan M. 2014. Identification and consequences of miRNA-target interactions–beyond repression of gene expression. Nat Rev Genet. 15(9):599–612. doi: 10.1038/nrg3765.
  • Hu C, Wang Y, Li A, Zhang J, Xue F, Zhu L. 2019. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis. J Cell Physiol. 234(6):9225–9232. doi: 10.1002/jcp.27601.
  • Karpathiou G, Da Cruz V, Casteillo F, Mobarki M, Dumollard JM, Chauleur C, Forest F, Prades JM, Peoc’h M. 2017. FOXA1 in HPV associated carcinomas: its expression in carcinomas of the head and neck and of the uterine cervix. Exp Mol Pathol. 102(2):230–236. doi: 10.1016/j.yexmp.2017.02.010.
  • Liu C, Mann D, Sinha UK, Kokot NC. 2018. The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review. J Otolaryngol Head Neck Surg. 47(1):59. doi: 10.1186/s40463-018-0302-y.
  • Liu D, Kang H, Gao M, Jin L, Zhang F, Chen D, Li M, Xiao L. 2020. Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Mol Oncol. 14(6):1365–1380. doi: 10.1002/1878-0261.12637.
  • Liu J, Wang D, Long Z, Liu J, Li W. 2018. CircRNA8924 promotes cervical cancer cell proliferation, migration and invasion by competitively binding to MiR-518d-5p/519-5p family and modulating the expression of CBX8. Cell Physiol Biochem. 48(1):173–184. doi: 10.1159/000491716.
  • Lv T, Miao Y, Xu T, Sun W, Sang Y, Jia F, Zhang X. 2020. Circ-EPB41L5 regulates the host gene EPB41L5 via sponging miR-19a to repress glioblastoma tumorigenesis. Aging. 12(1):318–339. doi: 10.18632/aging.102617.
  • Qiu L, Zhou R, Luo Z, Wu J, Jiang H. 2022. CDC27-ODC1 axis promotes metastasis, accelerates ferroptosis and predicts poor prognosis in neuroblastoma. Front Oncol. 12:774458. doi: 10.3389/fonc.2022.774458.
  • Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. 2013. Cell-type specific features of circular RNA expression. PLOS Genet. 9(9):e1003777. doi: 10.1371/journal.pgen.1003777.
  • Shang Q, Yang Z, Jia R, Ge S. 2019. The novel roles of circRNAs in human cancer. Mol Cancer. 18(1):6. doi: 10.1186/s12943-018-0934-6.
  • Wei J, Li M, Xue C, Chen S, Zheng L, Deng H, Tang F, Li G, Xiong W, Zeng Z, et al. 2023. Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. J Exp Clin Cancer Res. 42(1):86. doi: 10.1186/s13046-023-02657-6.
  • Yang M, Hu H, Wu S, Ding J, Yin B, Huang B, Li F, Guo X, Han L. 2022. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression. J Exp Clin Cancer Res. 41(1):165. doi: 10.1186/s13046-022-02368-4.
  • Yao Z, Luo J, Hu K, Lin J, Huang H, Wang Q, Zhang P, Xiong Z, He C, Huang Z, et al. 2017. ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways. Mol Oncol. 11(4):422–437. doi: 10.1002/1878-0261.12045.
  • Ye Z, Zeng Z, Shen Y, Yang Q, Chen D, Chen Z, Shen S. 2019. ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma. Onco Targets Ther. 12:4081–4092. doi: 10.2147/OTT.S198341.
  • Zhang H, Hua Y, Jiang Z, Yue J, Shi M, Zhen X, Zhang X, Yang L, Zhou R, Wu S. 2019. Cancer-associated fibroblast-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. 25(6):1989–2000. doi: 10.1158/1078-0432.CCR-18-0773.
  • Zheng SR, Zhang HR, Zhang ZF, Lai SY, Huang LJ, Liu J, Bai X, Ding K, Zhou JY. 2018. Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells. J Cancer. 9(20):3755–3764. eng. doi: 10.7150/jca.24253.
  • Zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2(5):342–350. eng. doi: 10.1038/nrc798.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.